Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Merck & Co. develops potent and selective pyridinone acetamide thrombin inhibitor

July 16, 1997

Lp(a)-dependent actions of LMWH

July 14, 1997

Antithrombotic efficacy of TAK-029 in animal models

July 11, 1997

Roberts seeks European approval of Agrylin

July 11, 1997

ReoPro effective in baboon models of human renal disorders

July 11, 1997

Factor Xa inhibitors from Berlex

July 11, 1997

Outcome in unstable angina improved with ReoPro

July 8, 1997

Novel antiplatelet agent from Cypress Bioscience

July 4, 1997

Effects of thrombin inhibitor with or without gpIIb/IIIa antagonist during coronary thrombolysis

July 3, 1997

Topical t-PA for the treatment of venous ulcers

July 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...